potassium chloride has been researched along with atrasentan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, N; Fuchs, LC; Giulumian, AD; Pollock, DM | 1 |
| Allan, A; Brown, L; Fenning, A; Hoey, A; Levick, S | 1 |
2 other study(ies) available for potassium chloride and atrasentan
| Article | Year |
|---|---|
Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Topics: Animals; Atrasentan; Blood Pressure; Coronary Vessels; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Hypertension; Male; Mesenteric Arteries; Potassium Chloride; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sodium Chloride; Vasoconstriction | 1998 |
Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
Topics: Acetylcholine; Action Potentials; Animals; Aorta, Thoracic; Atrasentan; Body Weight; Collagen; Desoxycorticosterone; Disease Models, Animal; Drinking; Endothelin A Receptor Antagonists; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardial Contraction; Nephrectomy; Norepinephrine; Papillary Muscles; Potassium Chloride; Pyrrolidines; Rats; Rats, Wistar; Ventricular Remodeling | 2005 |